Alanine Aminotransferase

Pyridoxal phosphate functions as the required cofactor that enables ALT to transfer an amino group between alanine and alpha-ketoglutarate. This supports formation of pyruvate and glutamate during the reversible reaction. Because the enzyme depends on this cofactor for its normal biochemical activity, the reaction links amino-acid metabolism with the laboratory measurement used to assess liver cell injury.

Hepatocytes contain abundant ALT, so injury to these cells can release the enzyme into the bloodstream. The measured concentration therefore reflects leakage associated with cellular damage rather than a direct measurement of liver function as a whole. This mechanism explains why hepatitis, fatty liver disease, and medication-related injury may be accompanied by increased results.

ALT connects alanine metabolism with the production of pyruvate and glutamate by transferring an amino group to alpha-ketoglutarate. Because the reaction is reversible, its direction depends on the participating substrates and products. In the clinical setting, however, the importance of this chemistry is that hepatocyte injury can increase the amount of this enzyme detectable in blood.

An ALT result supports clinical assessment but does not provide a complete interpretation by itself. Clinicians consider the value together with symptoms, medical history, and other laboratory findings. This broader evaluation helps place an elevated concentration in context, including possible hepatitis, fatty liver disease, or medication-related liver injury, without treating the test as a standalone diagnosis.

ALT testing is useful when clinicians are evaluating possible liver cell injury or following a known or suspected liver-related condition. It can contribute to assessment in hepatitis, fatty liver disease, and medication-related injury. The test also supports monitoring over time, with interpretation guided by the patient’s clinical information and accompanying laboratory results.

Repeated ALT measurements can support monitoring by showing whether blood concentrations remain elevated during clinical follow-up. The result is most informative when considered alongside symptoms, medical history, and other laboratory findings. This approach allows clinicians to evaluate the significance of changes in the enzyme concentration while investigating or following conditions associated with liver cell injury.